| Log in

Evolvence India Life Sciences Fund Invests Rs 25 Crore In Anjan Drugs

10 June, 2009
Evolvence India Life Sciences Fund (EILSF), a fund focused on investing in the life sciences space in India, has invested Rs 25 crore in Chennai-based pharmaceutical company, Anjan Drugs Pvt. Ltd. The company specialises in medicines used for the treatment of central nervous system (CNS) disorders. It is one of the largest US-FDA approved producers of Divalproex Sodium and various other salts of Valproic Acid.

The fund has assets worth $150 million under management and provides growth capital to Indian pharmaceutical and biotechnology companies. Last the year, the fund had invested $30 million in the Hyderabad based advanced drug delivery mechanism company, Gland Pharma.

EILSF has also invested about $5 million in Bangalore-based cancer centre network, Health Care Global.

EILSF is a fund sponsored by Evolvence Capital. The fund aims at investing in companies in the active pharmaceutical ingredients (APIs), contract research and manufacturing services (CRAMS), disease management and CRO spaces.

In the current times, healthcare is one of the few sectors continuing to get significant amounts of investments from the private equity and venture capital community. About two months back, Indian Angel Network invested $500,000 in Karmic Life Sciences, Mumbai based oncology focused contract research organisation (CRO). Similarly, Rx HealthCare Magic, which runs a healthcare portal HealthcareMagic.com, raised Series A funding of $2.5 million from Accel India in February this year.

Despite the slowdown in the economy, there still is a continuous flow of M&A activities in the healthcare sector, largely owing to the investor belief that this is one of the less-recession impacted sectors. Earlier this year, diagnostic chain Metropolis acquired two pathlabs in northern India. Yash Birla Group acquired a majority stake in Kerala Vaidyashala, an ayurvedic therapy centre chain, through a joint venture, in January.

Recently, Sabre Capital too set up a company called Spring Healthcare Ltd through which it plans to make investments of around Rs 250 crore in the Indian healthcare space.

 


Leave Your Comment
Interview: Hari Buggana On Why Evolvence Invested In Anjan Drugs

Interview: Hari Buggana On Why Evolvence Invested In Anjan Drugs

Ruchika Sharma 8 years ago
Evolvence India Life Sciences Fund (EILSF) recently invested Rs 25...
Evolvence Life Sciences Fund Backs Vivimed Buy With $12.5M Financing

Evolvence Life Sciences Fund Backs Vivimed Buy With $12.5M Financing

Madhav A Chanchani 6 years ago
Sector-focused private equity fund Evolvence India Life Sciences Fund has backed...
Evolvence Life Sciences Fund Invests Rs 35 Cr in Sutures India

Evolvence Life Sciences Fund Invests Rs 35 Cr in Sutures India

Madhav A Chanchani 8 years ago
Evolvence India Life Sciences Fund (EILSF) has invested upto Rs 35 crore in...
No Comments

Evolvence India Life Sciences Fund Invests Rs 25 Crore In Anjan Drugs

Powered by WordPress.com VIP